On March 22, 2010
Vote of Confidence for Gene Therapy: $35 Million for Genetix Pharmaceuticals:
Genetix Pharmaceuticals, Inc. one of the leading companies in gene therapy, has secured $35 million in series B funding from investors Third Rock Ventures and Genezyme Joint Ventures. This is a sign that investors are starting to take gene therapy,
…
0 Comments